These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 16823938)

  • 41. Studies on the adjuvant effect of water-in-oil-in-water (w/o/w) emulsion of sesame oil. 1. Enhanced and persistent antibody formation by antigen incorporated into the water-in-oil-in-water emulsion.
    Kimura J; Nariuchi H; Watanabe T; Matuhasi T; Okayasu I; Hatakeyama S
    Jpn J Exp Med; 1978 Apr; 48(2):149-54. PubMed ID: 713123
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Starch microparticles as vaccine adjuvant.
    Rydell N; Stertman L; Sjöholm I
    Expert Opin Drug Deliv; 2005 Sep; 2(5):807-28. PubMed ID: 16296780
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Carbohydrate-based vaccine adjuvants - discovery and development.
    Hu J; Qiu L; Wang X; Zou X; Lu M; Yin J
    Expert Opin Drug Discov; 2015 Oct; 10(10):1133-44. PubMed ID: 26372693
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Unsaturated Squalene Content in Emulsion Vaccine Adjuvants Plays a Crucial Role in ROS-Mediated Antigen Uptake and Cellular Immunity.
    Huang CH; Huang CY; Huang MH
    Mol Pharm; 2018 Feb; 15(2):420-429. PubMed ID: 29237267
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The adjuvant activity of fatty acid esters. The role of acyl chain length and degree of saturation.
    Bomford R
    Immunology; 1981 Sep; 44(1):187-92. PubMed ID: 7275184
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The adjuvant effect of MF59 is due to the oil-in-water emulsion formulation, none of the individual components induce a comparable adjuvant effect.
    Calabro S; Tritto E; Pezzotti A; Taccone M; Muzzi A; Bertholet S; De Gregorio E; O'Hagan DT; Baudner B; Seubert A
    Vaccine; 2013 Jul; 31(33):3363-9. PubMed ID: 23684834
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Unmet needs in modern vaccinology: adjuvants to improve the immune response.
    Leroux-Roels G
    Vaccine; 2010 Aug; 28 Suppl 3():C25-36. PubMed ID: 20713254
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Design and selection of vaccine adjuvants: animal models and human trials.
    Alving CR
    Vaccine; 2002 May; 20 Suppl 3():S56-64. PubMed ID: 12184368
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Synergistic effect of dual targeting vaccine adjuvant with aminated β-glucan and CpG-oligodeoxynucleotides for both humoral and cellular immune responses.
    Jin JW; Tang SQ; Rong MZ; Zhang MQ
    Acta Biomater; 2018 Sep; 78():211-223. PubMed ID: 30098441
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Adjuvants--a balance between toxicity and adjuvanticity.
    Gupta RK; Relyveld EH; Lindblad EB; Bizzini B; Ben-Efraim S; Gupta CK
    Vaccine; 1993; 11(3):293-306. PubMed ID: 8447157
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Studies on adjuvants for human prophylactics. II. Influence of the route of injection on the activity of adjuvants to tetanus toxoid in guinea pigs.
    Yamamoto A; Murata R
    Jpn J Med Sci Biol; 1978; 31(5-6):393-406. PubMed ID: 156804
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A new approach to vaccine adjuvants. Immunopotentiation by intracellular T-helper-like signals transmitted by loxoribine.
    Goodman MG
    Pharm Biotechnol; 1995; 6():581-609. PubMed ID: 7551237
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Squalene-based oil-in-water emulsion adjuvants perturb metabolism of neutral lipids and enhance lipid droplet formation.
    Kalvodova L
    Biochem Biophys Res Commun; 2010 Mar; 393(3):350-5. PubMed ID: 20018176
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Conserved peptides enhance immune efficiency of inactive vaccines against emerging avian influenza viruses in chicken.
    Xiao J; Zhang L; Wang Z; Xiang W; Lu P; Zhao Y; Han M; Ma A; Qi P; Wang M; Gao GF; Liu WJ
    Sci China Life Sci; 2017 Dec; 60(12):1340-1347. PubMed ID: 29230639
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Characterization of a novel oil-in-water emulsion adjuvant for swine influenza virus and Mycoplasma hyopneumoniae vaccines.
    Galliher-Beckley A; Pappan LK; Madera R; Burakova Y; Waters A; Nickles M; Li X; Nietfeld J; Schlup JR; Zhong Q; McVey S; Dritz SS; Shi J
    Vaccine; 2015 Jun; 33(25):2903-8. PubMed ID: 25936722
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Adjuvants in perspective.
    Vogel FR
    Dev Biol Stand; 1998; 92():241-8. PubMed ID: 9554280
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Construction of a stable w/o nano-emulsion as a potential adjuvant for foot and mouth disease virus vaccine.
    Chen Z; Zhang S; Li Z; Ma G; Su Z
    Artif Cells Nanomed Biotechnol; 2017 Aug; 45(5):897-906. PubMed ID: 27322345
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Modes of Action for Mucosal Vaccine Adjuvants.
    Aoshi T
    Viral Immunol; 2017; 30(6):463-470. PubMed ID: 28436755
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Norovirus (NoV) specific protective immune responses induced by recombinant P dimer vaccine are enhanced by the mucosal adjuvant FlaB.
    Verma V; Tan W; Puth S; Cho KO; Lee SE; Rhee JH
    J Transl Med; 2016 May; 14(1):135. PubMed ID: 27184355
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparative assessment of humoral immune responses of aluminum hydroxide and oil-emulsion adjuvants in Influenza (H9N2) and Newcastle inactive vaccines to chickens.
    Jafari M; Moghaddam Pour M; Taghizadeh M; Masoudi S; Bayat Z
    Artif Cells Nanomed Biotechnol; 2017 Feb; 45(1):84-89. PubMed ID: 26757848
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.